
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies
Leilei Yu, Yaru Liu, Shunhe Wang, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Leilei Yu, Yaru Liu, Shunhe Wang, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Achieving healthy aging through gut microbiota-directed dietary intervention: Focusing on microbial biomarkers and host mechanisms
Yue Xiao, Yingxuan Feng, Jianxin Zhao, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 17
Yue Xiao, Yingxuan Feng, Jianxin Zhao, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 17
Interkingdom signaling between gastrointestinal hormones and the gut microbiome
Xinyu Zhao, Ye Qiu, Lanfan Liang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Xinyu Zhao, Ye Qiu, Lanfan Liang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Hepatoprotective effects of natural drugs: Current trends, scope, relevance and future perspectives
Sonal Datta, Diwakar Aggarwal, Nirmala Sehrawat, et al.
Phytomedicine (2023) Vol. 121, pp. 155100-155100
Closed Access | Times Cited: 20
Sonal Datta, Diwakar Aggarwal, Nirmala Sehrawat, et al.
Phytomedicine (2023) Vol. 121, pp. 155100-155100
Closed Access | Times Cited: 20
Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
Qingmiao Shi, Xin Yuan, Yifan Zeng, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2411-2411
Open Access | Times Cited: 13
Qingmiao Shi, Xin Yuan, Yifan Zeng, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2411-2411
Open Access | Times Cited: 13
Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice
Yuzhe Huang, Hao Chen, Jielin Chen, et al.
Phytomedicine (2024) Vol. 133, pp. 155919-155919
Closed Access | Times Cited: 5
Yuzhe Huang, Hao Chen, Jielin Chen, et al.
Phytomedicine (2024) Vol. 133, pp. 155919-155919
Closed Access | Times Cited: 5
Hyperlipidaemia treatment and gut microbiology
Zhe Liu, Yu ChunLi
Frontiers in Microbiology (2025) Vol. 15
Open Access
Zhe Liu, Yu ChunLi
Frontiers in Microbiology (2025) Vol. 15
Open Access
Role of gut microbiota and fecal metabolites in the protective effect of soybean pulp-rich diet against estrogen-induced cholestasis in rats
Jiawei Wang, Qichao Hu, Jianying Wang, et al.
Current Research in Food Science (2025) Vol. 10, pp. 100990-100990
Open Access
Jiawei Wang, Qichao Hu, Jianying Wang, et al.
Current Research in Food Science (2025) Vol. 10, pp. 100990-100990
Open Access
MiR-128-3p mediates MRP2 internalization in estrogen-induced cholestasis through targeting PDZK1
Yue Zu, Qianyan Gao, Yisheng He, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Yue Zu, Qianyan Gao, Yisheng He, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Yinzhihuang formula modulates the microbe‒gut‒liver axis and bile acid excretion to attenuate cholestatic liver injury
Xin Luo, Peng Cheng, Yuan Fang, et al.
Phytomedicine (2025) Vol. 139, pp. 156495-156495
Closed Access
Xin Luo, Peng Cheng, Yuan Fang, et al.
Phytomedicine (2025) Vol. 139, pp. 156495-156495
Closed Access
Leveraging machine learning for precision medicine: a predictive model for cognitive impairment in cholestasis patients
Fang Cheng, Lina Zhang, Lanlan Xu, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Fang Cheng, Lina Zhang, Lanlan Xu, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Short-chain fatty acids alleviate cholestatic liver injury by improving gut microbiota and bile acid metabolism
Lu Han, Mingmin Zhang, Yanan Hu, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114564-114564
Closed Access
Lu Han, Mingmin Zhang, Yanan Hu, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114564-114564
Closed Access
A High-Fat, High-Cholesterol Diet Promotes Intestinal Inflammation by Exacerbating Gut Microbiome Dysbiosis and Bile Acid Disorders in Cholecystectomy
Fusheng Xu, Zhiming Yu, Yaru Liu, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3829-3829
Open Access | Times Cited: 12
Fusheng Xu, Zhiming Yu, Yaru Liu, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3829-3829
Open Access | Times Cited: 12
An Overview of the Role of Peroxisome Proliferator-activated Receptors in Liver Diseases
Zahra Changizi, Forough Kajbaf, Azam Moslehi
Journal of Clinical and Translational Hepatology (2023) Vol. 11, Iss. 7, pp. 1542-1552
Open Access | Times Cited: 10
Zahra Changizi, Forough Kajbaf, Azam Moslehi
Journal of Clinical and Translational Hepatology (2023) Vol. 11, Iss. 7, pp. 1542-1552
Open Access | Times Cited: 10
Updated Insights into Probiotics and Hepatobiliary Diseases
Xiaoyu Xu, Cheng Zhang, Guo‐Yi Tang, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 515-515
Open Access | Times Cited: 3
Xiaoyu Xu, Cheng Zhang, Guo‐Yi Tang, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 515-515
Open Access | Times Cited: 3
Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota–Bile Acid–Immunity Network
Ziqi Guo, Kun He, Ke Pang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4321-4321
Open Access | Times Cited: 3
Ziqi Guo, Kun He, Ke Pang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4321-4321
Open Access | Times Cited: 3
Bile acid-gut microbiota imbalance in cholestasis and its long-term effect in mice
Xin Yang, Yuesong Xu, Jiakui Li, et al.
mSystems (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 3
Xin Yang, Yuesong Xu, Jiakui Li, et al.
mSystems (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 3
Probiotic Pediococcus pentosaceus Li05 Improves Cholestasis through the FXR-SHP and FXR-FGF15 Pathways
Shengyi Han, Kaicen Wang, Jian Shen, et al.
Nutrients (2023) Vol. 15, Iss. 23, pp. 4864-4864
Open Access | Times Cited: 8
Shengyi Han, Kaicen Wang, Jian Shen, et al.
Nutrients (2023) Vol. 15, Iss. 23, pp. 4864-4864
Open Access | Times Cited: 8
Microbial Fermentation Enhances the Effect of Black Tea on Hyperlipidemia by Mediating Bile Acid Metabolism and Remodeling Intestinal Microbes
Lingli Sun, Lianghua Wen, Qiuhua Li, et al.
Nutrients (2024) Vol. 16, Iss. 7, pp. 998-998
Open Access | Times Cited: 2
Lingli Sun, Lianghua Wen, Qiuhua Li, et al.
Nutrients (2024) Vol. 16, Iss. 7, pp. 998-998
Open Access | Times Cited: 2
Protective effects of cilostazol via the HNF1α/FXR signalling pathway and anti-apoptotic mechanisms in a rat model of estrogen-induced intrahepatic cholestasis
Marwa Hassan, Maha B. Salem, Olfat Hammam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Marwa Hassan, Maha B. Salem, Olfat Hammam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
The anti-cholestatic effects of Coptis chinensis Franch. alone and combined with Tetradium ruticarpum (A. Jussieu) T. G. Hartley: dual effects on fecal metabolism and microbial diversity
Jun Han, Peijie Wu, Zongying Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Jun Han, Peijie Wu, Zongying Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota-Bile Acid-Immunity Network
Ziqi Guo, Kun He, Ke Pang, et al.
(2024)
Open Access | Times Cited: 1
Ziqi Guo, Kun He, Ke Pang, et al.
(2024)
Open Access | Times Cited: 1
Hepatic protein phosphatase 1 regulatory subunit 3G alleviates obesity and liver steatosis by regulating the gut microbiota and bile acid metabolism
Chu Zhang, Wang Gui, Xin Yin, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 8, pp. 100976-100976
Open Access | Times Cited: 1
Chu Zhang, Wang Gui, Xin Yin, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 8, pp. 100976-100976
Open Access | Times Cited: 1
Fecal Bile Acids in Canine Chronic Liver Disease: Results from 46 Dogs
Verena Habermaass, Francesco Bartoli, Eleonora Gori, et al.
Animals (2024) Vol. 14, Iss. 21, pp. 3051-3051
Open Access | Times Cited: 1
Verena Habermaass, Francesco Bartoli, Eleonora Gori, et al.
Animals (2024) Vol. 14, Iss. 21, pp. 3051-3051
Open Access | Times Cited: 1
Hepatoprotective, Lipid-Lowering and Antioxidant Effects of Mangaba Powder (Hancornia speciosa) Administered to Rats Fed a High-Fat Diet
Bernadete de Lourdes de Araújo Silva, Margarida Angélica da Silva Vasconcelos, Kamila Sabino Batista, et al.
Foods (2024) Vol. 13, Iss. 23, pp. 3773-3773
Open Access | Times Cited: 1
Bernadete de Lourdes de Araújo Silva, Margarida Angélica da Silva Vasconcelos, Kamila Sabino Batista, et al.
Foods (2024) Vol. 13, Iss. 23, pp. 3773-3773
Open Access | Times Cited: 1
The efficacy of L-carnitine in patients with nonalcoholic steatohepatitis and concomitant obesity
Natalia Zakharova, Chenguang Luo, Raisa Aringazina, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Natalia Zakharova, Chenguang Luo, Raisa Aringazina, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 2